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Introduction. Vestibular schwannomas (VS) are benign tumours of the vestibular nerve and can lead to hearing loss, tinnitus,
vertigo, facial palsy, and brainstem compression. Audiovestibular diagnostic tests are essential for detection and treatment planning.
Methods. Medline was used to perform a systematic literature review with regard to how audiovestibular test parameters correlate
with symptoms, tumour size, and tumour location. Results. The auditory brainstem response can be used to diagnose retrocochlear
lesions caused by VS. Since hearing loss correlates poorly with tumour size, a retrocochlear lesion is probably not the only cause
for hearing loss. Also cochlear mechanisms seem to play a role. This can be revealed by abnormal otoacoustic emissions, despite
normal ABR and newMRI techniques which have demonstrated endolymphatic hydrops of the inner ear. Caloric and head impulse
tests show frequency specific dynamics and vestibular evoked myogenic potentials may help to identify the location of the tumour
regarding the involved nerve parts. Conclusion. In order to preserve audiovestibular function in VS, it is important to stop the
growth of the tumour and to avoid degenerative changes in the inner ear. A detailed neurotological workup helps to diagnose VS
of all sizes and can also provide useful prognostic information.
1. Introduction
Vestibular schwannoma (VS) can lead to sensorineural hear-
ing loss, tinnitus, and vertigo. Patients with asymmetric hear-
ing loss, unilateral tinnitus, or vertigo should be evaluated for
the presence of a VS.
VS are benign tumours arising from the sheath of the
vestibular nerve. They cause dysfunction of the nerves by
compressing the nerve fibre and obstructing the blood supply
to the nerves [1, 2]. VS may present with a variety of clinical
features. Hearing loss is the most common first symptom
while vertigo is often the most distressing symptom for the
patient. However, hearing loss may also be absent in case of
an extrametal growth pattern.
The estimated annual incidence of these tumours ranges
from approximately 0.6 to 1.9 per 100,000 [3].
Currently there exist several classifications of VS, based
on the tumour size and location. Table 1 gives a summary of
the two most common classifications according to Koos and
Samii.
Audiovestibular function tests, such as pure tone
audiometry (PTA), otoacoustic emissions (OAEs), auditory
brainstem response (ABR), caloric irrigation, head impulse
test (HIT), and vestibular evoked myogenic potentials
(cVEMPs and oVEMPs) are important for initial diagnosis as
well as subsequent monitoring of disease progression.
The current gold standard of diagnosis is MR imaging,
but becauseMRI scans are expensive, they are not universally
utilized to screen all patients with audiovestibular symptoms
[4]. Thus, VS may be misdiagnosed as a peripheral disease,
such as noise-induced hearing loss, presbyacusis, tinnitus,
vestibulopathy, Menière’s disease, or sudden deafness with
vertigo.
Furthermore, precise preoperative audiovestibular
assessment can have implications on the decision of the
therapeutic approach such as wait and scan, radiotherapy, or
microsurgery.
2. Methods
English and German articles published between 1972 and
2016 and available on Medline were reviewed in order to
produce a summary of the current knowledge with regard
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Table 1: Tumour classification according to Koos et al. [24] and Samii and Matthies [25].
Grade (Koos et al.) Grade (Samii and Matthies) Definition of tumour size
I T1 Purely intracanalicular lesion
II T2 VS protruding into the cerebellopontine angle without brainstem contact
IIa T2 Tumour diameter < 1 cm
IIB T2 Tumour diameter 1–1,8 cm
III T3a Filling cerebellopontine angle cistern
T3b Reaching the brainstem
IV T4a Brain stem compression
T4b Severely dislocating the brainstem and compressing the fourth ventricle
to audiovestibular functional changes in patients with VS as
diagnosed by MR imaging.
3. Results
3.1. Audiological Function Tests
3.1.1. Vestibular Schwannomas and Audiometry. Sudden sen-
sorineural hearing loss may be an initial symptom of a VS [5];
therefore, audiometry has been regarded as an initial step in
the diagnostic workup for VS.
It has been shown that VS has been diagnosed in 0.8–
47.5% of patients with sudden sensorineural hearing loss
[6, 7].
To investigate predictive factors or symptoms of future
hearing loss Jethanamest et al. retrospectively reviewed
patients between 2002 and 2013 who chose observation for
their initial management. The estimated median time to loss
of serviceable hearing was 6.3 years. No symptoms or factors
were identified to be predictive of future hearing loss. How-
ever, symptoms of disequilibrium or imbalance appeared to
be associated with an increased risk of subsequent tumour
growth [8].
Wagner et al. found that the degree of hearing loss before
treatment is significantly influenced by the age of the patient
(𝑝 < 0.001) but not by tumour size. At follow-up exami-
nations after treatment with microsurgery and radiotherapy,
hearing was significantly worse in those patients with a large
VS. Age was not a significant determinant for loss of hearing
on the follow-up visits (𝑝 < 0.08) [9].
Another study noted that 45% of those patients who
initially had a hearing ability of AAO class A on the tumour
affected side lost class A hearing after 5 years [10].
Concerning speech discrimination, Stangerup et al.
demonstrated during a 33-year period that 59%of the patients
with a speech discrimination better than 70% preserved good
hearing after a mean of 4.7 years of observation. 69% of
the patients with a speech discrimination score of 100% at
diagnosis maintained good hearing after more than 10 years.
Of the patients with only a small discrimination loss at
diagnosis, 38% maintained good hearing [11].
Tumour growth less than or equal to 2.5 millimeters
per year has been shown to lead to higher rates of hearing
preservation. For patients with a small tumour and normal
speech discrimination, the main indication for active treat-
ment should be the established tumour growth [11, 12].
Day et al. found in a total of 44 patients that normal
hearing or low-frequency hearing loss was correlated with
small tumour size. Those with mid- or high-frequency
hearing loss had a medium-sized tumour, while those with
global frequency hearing loss or total deafness had tumour
size larger than 2.5 cm. The authors explained the hearing
loss by tumour compression of the cochlear nerve, sincemost
VS originate from the vestibular nerve [13]. This association
of small tumour size with low-frequency hearing loss may
suggest the presence of endolymphatic hydrops in some of
these patients, since hydrops is typically associated with low-
frequency hearing loss.
Concerning primary inner ear schwannomas (PIES), that
is, schwannomas arising from the labyrinth, a systematic
review of 243 patients diagnosed from 1933 to 2011 showed
that unilateral hearing loss was the most frequent presenting
symptom (99%). Vertigo and abnormal balance were more
common among tumours involving the vestibular system
(𝑝 < 0.01) [14]. Positional vestibular symptoms and mixed
hearing loss occur especially in intralabyrinthine schwan-
nomas and are suggested to result from the tumour’s mass
effectwithin the labyrinth [15]. Especially in intralabyrinthine
schwannoma a diagnostic delay of up to 15 years has been
reported. Since radiographic findings in MRI may be very
subtle, intralabyrinthine schwannomas can easily be over-
looked, so that they are frequently diagnosed only years after
the onset of symptoms [16].
Overall, there is limited data on the long-term auditory
symptoms in patientswith sporadic small- andmedium-sized
VS. The initial treatment strategy for VS is being discussed
controversially. The overall prognosis for hearing in sporadic
VS is poor regardless of treatment strategy. Good baseline
hearing proved to be a strong predictor for maintained
serviceable hearing. Observation was associated with the
highest rate of hearing preservation [17], although this might
be due to a selection bias.
3.1.2. Vestibular Schwannomas and ABR. After audiometry,
the next diagnostic test of choice for patients with clinical
suspicion of a VS (unilateral or asymmetrical sensorineural
hearing loss) was the ABR. However, with improvements in
MRI diagnostics in the late 1980s, the usefulness of the ABR
in the diagnostic workup of VS has diminished and MRI
is nowadays widely considered to be the gold standard for
diagnosing retrocochlear pathology.
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Currently, the role of the ABR remains controversial. The
criteria for assessing abnormal responses on ABR tests have
varied considerably among studies. Some authors argue that
the ABR has no place in today’s management and that MRI
should be the initial screening test when there is a suspicion
of VS [18]. Other authors argue that there is still a place for
the ABR in the diagnostic algorithm due to the high cost and
lower availability of MRI [19].
The ABR has a high dependency on the tumour size and
the diagnostic sensitivity is especially low for smaller tumours
[20].
This was also shown in a study by Koos et al. in which
multiple online databases were assessed in order to evaluate
the usefulness of ABR tests in 3314 patients from 1978 to
2009. The inclusion criterion was the presence of a surgically
or radiographically confirmed VS. The pooled sensitivity
of ABR was 93.4%, 85.8% for tumours < 1 cm, and 95.6%
for tumours > 1 cm. Moreover, the sensitivity of ABR was
higher for extracanalicular than for intracanalicular tumours.
The authors concluded that for patients with lower clinical
suspicion of a VS an ABR can still provide valuable additional
information on which the decision to obtain an MRI can be
based.
However, a small number of tumours with audiometri-
cally documented hearing loss demonstrate a normal ABR
[21], which supports the hypothesis that schwannomas can
also cause hearing loss by purely cochlear mechanisms.
3.1.3. Vestibular Schwannomas and Otoacoustic Emissions.
OAEs are active mechanical responses from the cochlea
which provide information about the integrity of the preneu-
ral cochlear receptor mechanisms. Clinical experience has
shown that OAEs are often absent or compromised in VS.
In order to objectify the effects of retrocochlear disease on
distortion-product otoacoustic emissions (DPOAEs) Telishi
et al. classified the DPOAE patterns as cochlear or non-
cochlear. In a large series of patients with unilateral VS they
showed that the majority of ears with tumours demonstrated
cochlear (57%), rather than noncochlear (41%) patterns of
DPOAEs [22].
The occurrence of cochlear pathology has implications
regarding the accuracy of OAEs as a diagnostic tool for
VS. If one assumes that VS affect the retrocochlear function
(hearing impairment is purely neural in origin) and have
little effect on the cochlea itself then VS patients should
have preserved OAEs. However, it seems that amplitudes
of DPOAEs begin to decrease already at the early stages of
hearing loss in VS patients. Comparing a group of VS patients
with normal/symmetrical hearing and a group of VS patients
with mild hearing loss (threshold at any tested frequency
better than 45 dB) on the tumour ear side, Gouveris et
al. showed that DPOAE amplitudes do not differ strongly
between the ears in VS patients with normal/symmetrical
hearing. But DPOAEs are decreased compared with the
nontumour ear in VS patients with even mild hearing loss.
The tumour size did not differ significantly between these
two groups, which suggests a cochlear origin of early hearing
loss in these patients. The authors conclude that DPOAEs
may be used in a clinical setting to monitor progression of
cochlear damage at the early stages of hearing impairment in
VS patients [23].
3.2. Vestibular Function Tests
3.2.1. Vestibular Schwannomas and Caloric Response. Vertigo
has been reported to be one of the risk factors for the
growth of VS [26]. Therefore, vestibular function tests such
as the caloric test should be used routinely in the workup
of VS. By using videonystagmography (VNG) or electronys-
tagmography (ENG), caloric responses can be observed
and quantified in terms of slow-phase nystagmus velocities
generated during warm and cold irrigations of each ear. The
asymmetry between the two horizontal semicircular canals is
usually calculated by the Jongkees formula. When unilateral
weakness (UW) is less than 25%, the caloric response is
regarded as normal.
With the caloric test it is possible to unilaterally stimulate
the horizontal semicircular canal, which is innervated by
the superior part of the vestibular nerve. Thus, one might
think that the caloric response is only significant when the
superior branch of the vestibular nerve is affected by the VS.
Borgmann et al. tested whether ENG results could predict
the nerve of origin before surgery. They defined pathologic
caloric test findings as an indicator for superior vestibular
nerve schwannomas (SVN) involvement and a normal caloric
response as a sign of inferior vestibular nerve schwannomas
(IVN) origin. As a result, the nerve of origin could be
predicted in 90 of 111 patients (81%), which means that
pathologic results in preoperative ENG were significantly
more frequent in patients with SVN schwannomas. They
concluded that the caloric test helps to predict the nerve of
origin of aVS and can be used indirectly as a prognostic factor
for hearing preservation because hearing loss due to surgery
was significantly lower in patients with tumours of the SVN
[27].
In contrast Ushio et al. demonstrated in a study of 109
VS patients that the percentage of abnormal responses in
caloric tests was not different between patients with SVN and
those with IVN [2].These results showed no clear correlation
between the results of caloric tests and the nerve origin of the
tumour.
Tringali et al. observed a good correlation between caloric
weakness and tumour size when they tested the preoperative
response of 629 tumour patients. In the group of patients with
UW> 70%,who had a larger tumour size, postoperative facial
palsy was more frequent. Postoperative hearing preservation
was more frequently observed in the “normal group” with a
UW < 20%. They concluded that a normal caloric response
can be a good predictive factor for hearing preservation and
normal postoperative facial function [28].
In a prospective pilot study on patients with VS, Wagner
et al. compared groups with VS < 20mm and ≥ 20mm. In
group 1, the median loss of vestibular function was +10.5%;
in group 2 (with a tumour size ≥ 20mm) a higher degree
of loss of vestibular function (median UW 36%) was found.
Treatment by micro- and radiosurgery caused a further
decrease of vestibular function in both groups. So vestibular
function clearly correlated with the size of the tumour and
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also with the method of treatment used. The majority of
patients complained about vertigo before and after treatment
[9].
Ushio et al. also found that the mean tumour size in
patients showing abnormal responses in caloric testing was
larger than that in patients showing normal responses. This
tendency was not observed for patients with VS within
the internal acoustic canal [2]. The same observation was
made by Suzuki in patients with unilateral VS histologically
diagnosed by surgery. There was no significant difference
between patients with normal caloric responses and those
with canal paresis with respect to the size of the tumour
measured for intracanalicular tumours [29].
On the contrary, the results of a study by Teggi et al.
showed that vestibular function is influenced by intracanalic-
ular length and diameter of the tumour, rather than by total
tumour volume. The subgroup of 30 patients with a greater
intracanalicular length of the tumour presented a higher
value of UW than the subgroup with a smaller length [30].
In summary, the available data suggest that the severity
of the UW correlates with degree of infiltration of the
cochleovestibular nerve by the tumour. This means that an
abnormal caloric response is a prognostic factor for hearing
preservation surgery [31].
3.2.2. Vestibular Schwannomas and Head Impulse Test. Both
the caloric irrigation and the head impulse test (HIT) serve
to evaluate the horizontal vestibuloocular reflex (VOR).
The HIT applies high-acceleration small-amplitude head
impulses around an earth-vertical axis while the patient is
fixating a stationary target. A catch-up saccade is observed
if the eye no longer compensates for the head movement and
accordingly this test is classified as pathologic.Theprobability
of a pathologic HIT generally increases with increasing UW
of caloric examination. For patientswith aUWwithin normal
limits, a pathological HIT is very unlikely [32].
At present the HIT is the only bedside examination
that enables the identification of the side of a unilateral
hypofunction of the peripheral vestibular system.
However, a VOR deficit may not be diagnosed because
corrective saccades cannot always be detected by simple
observation. Besides the manual HIT as described by Hal-
magyi et al. [33], which can be performed quickly as a bedside
test, there is the video head impulse test (vHIT). This allows
the identification not only of overt saccades but also of covert
saccades occurring during the head movement which are not
visible to the naked eye.
2013 Blödow et al. examined 142 patients with acute or
chronic vestibular syndrome and found that 47.6% had a
pathological vHIT whereas 52.4% had a normal test result.
Covert catch-up saccades could be demonstrated in 13.7%
whereas in 86.3% overt catch-up saccades alone or in combi-
nationwith covert catch-up saccades were found.The authors
concluded that the vHIT is superior to the clinical HIT
because in approximately one in eight cases with acute or
chronic peripheral vestibular syndrome a covert catch-up
saccade can be detected, which would otherwise have been
undetectable by the clinical HIT [34].
The same group recently examined 46 patients with VS
and showed that caloric irrigation exhibits a higher sensitivity
than HIT (72% versus 41%) and both tests show only a
moderate correlation. Tumour size and hearing level were
significantly correlated with caloric abnormalities but not
with HIT findings [35].
The finding of a selective impairment of the VOR in the
low-frequency range (caloric) was also shown in a case of an
intralabyrinthine schwannoma, whereas the high-frequency
VOR (HIT) remains intact [36]. This constellation is typical
for Menière’s disease.
However, neither study could find an explanation for the
higher sensitivity of the caloric test. Both tests measure the
VOR but at different temporal frequencies: the HIT with
short head impulses tests high frequencies up to 5Hz [37] and
the caloric irrigation tests lower frequencies around 0.003Hz
[33].
Vestibular testing at different frequencies provides deeper
insights into VOR function and can help in detecting cerebel-
lopontine lesions. According to the current literature, both
tests have to be considered complementary and are valuable
for both diagnostic and therapeutic decisions.
The HIT and the bithermal caloric irrigation are different
in terms of not only temporal frequency, but also the method
of stimulation. The HIT causes a physiologic endolymphatic
flow as a consequence of rapid head impulses. In contrast,
caloric irrigation induces endolymphatic flow due to a tem-
perature gradient from one side of the canal to the other.
Caloric irrigation additionally stimulates the inner ear in a
non-gravity-dependent way [38].
It still remains unclear whether the dissociation of the
caloric test and the HIT in patients with VS is due to
the varying temporal frequencies or the differing methods
of stimulation. Of note, the predilection for caloric test
abnormality is typical for patients with Menière’s disease (as
opposed to, e.g., vestibular neuritis which typically affects
both tests) and has been shown to correlate with the degree
of endolymphatic hydrops herniation into the horizontal
semicircular canal. Therefore, this feature might suggest
endolymphatic hydrops in some of these patients.
3.2.3. Vestibular Schwannomas and VEMPs. VEMPs pro-
vide information on otolith organ function. The conven-
tional method for recording VEMPs involves measuring
electromyographic activity from surface electrodes placed
over the tonically activated sternocleidomastoidmuscles.The
cervical VEMP (cVEMP) is a manifestation of the vestibu-
locollic reflex [39]. VEMPs can also be recorded from the
extraocular muscles using surface electrodes placed near the
eyes. These ocular VEMPs (oVEMPs) are a manifestation of
the vestibuloocular reflex [40]. Stimulation of the vestibular
system is possible using air-conducted sound (ACS) and
bone-conducted vibration (BCV).
In recent years the role of cVEMPs and oVEMPs in
the assessment of patients with VS has gained increased
attention. A number of studies have demonstrated that
VEMPs have an important clinical value in the diagnosis of
VS because sometimes an abnormal VEMP result may be the
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only sign of a unilateral VS (the caloric and hearing test being
normal) [41].
Physiological and clinical studies have shown that
cVEMPs to ACS mainly reflect the function of saccular
afferents and the inferior vestibular pathway [42–44].
On the contrary, clinical studies in patientswith unilateral
VS [45, 46] and animal studies using guinea pigs [47] have
suggested that oVEMPs to BCV are likely to reflect the
function of the utricle and superior vestibular pathway.
Recently VEMPs have been applied especially for classi-
fying VS according to the involved nerves prior to surgery or
radiotherapy.
Iwasaki et al. postulated that BCV oVEMPsmainly reflect
the function of the SVN. They hypothesised that if the
oVEMPs to BCV mainly reflect the function of the utricular
afferents, the results should mostly coincide with those of
the caloric test rather than with cVEMPs to ACS. Among
ten patients with inconsistent results in these three vestibular
tests, seven (70%) showed corresponding results between
oVEMPs to BCV and the caloric test, whereas only one
patient (10%) showed correspondence between oVEMPs to
BCV and cVEMPs to ACS [46], thus supporting the authors’
hypothesis.
In a bigger cohort of 45 patients with untreated unilateral
VS, the results of oVEMPs to ACS had a significant correla-
tion with those of oVEMPs to BCV. These findings support
the hypothesis that oVEMPs in response to both ACS and
BCV are predominantly mediated by the superior vestibular
nerve and probably both reflect the function of the utricle
[48].
However, according to other studies the nerve of origin
of tumours cannot be predicted based on VEMPs. In a
study of 130 patients histologically diagnosed by surgery,
VEMPs in patients with tumours arising from the SVN
were not significantly different from those in patients with
tumours of the IVN [29]. Ushio et al. also could not find a
clear correlation of VEMP results with the nerve origin of
the tumour. The percentage of patients showing abnormal
responseswas not different between 37 patients withVS of the
SVN and 26 patients with VS of the IVN. Also, no difference
was observed for patients withVSwithin the internal acoustic
canal.The authors hypothesised that large VS affect functions
of both the SVN and the IVN, irrespective of the nerve origin,
because the space of the internal acoustic canal is limited
[2]. As a result tumours injure or compress both parts of
the vestibular nerve as they grow. Complicating matters even
further, it is likely that these efforts to predict the affected
nerve can also be obscured by diffuse labyrinthine damage.
With regard to tumour size, several authors describe that,
in VS, ACS cVEMPs are absent or decreased in amplitude in
up to 80% of cases [49–51]. The amplitude decreases in asso-
ciation with an increase in tumour size. Larger tumours and
those located more medially are more commonly associated
with cVEMP abnormalities [13, 52].
Tumour compression of the brainstem and the vestibular
spinal tract and compression of themyelin sheath of the IVN,
resulting in demyelination of the nerve, were also correlated
with cVEMP latencies [29, 46].
However, comparing the tumour size within the internal
acoustic canal, Ushio et al. could not observe a difference
Vestibular
schwannoma
Figure 1: A vestibular schwannoma shown in a contrast-enhanced
T1-weighted sequence.
between patients showing abnormal VEMP responses and
patients showing normal responses [2].
In summary, there exists at the moment no consensus
about the use of VEMPS in detecting a VS. So it seems
currently not possible to make any diagnostic prognosis
through VEMPS.
3.3. What Could Be the Most Probable Cause of Symptoms
Like Hearing Loss or Vertigo in Patients with VS? Since it
is not yet clear whether there are symptoms or parameters
(such as tumour growth) which can be used to predict future
hearing outcomes inVS patients, onemight raise the question
whether the hearing loss is caused by retrocochlear or
cochlear mechanisms. Clinical and histological observations
have suggested that the hearing loss in VS does not correlate
with the size of the VS [53, 54], indicating that compression
of the cochlear nerve within the internal auditory canal may
not be the only mechanism in hearing loss. In other words,
it may be that the commonly observed pure tone hearing loss
patterns in patients withVSmay be caused by cochlear, rather
than exclusively retrocochlear mechanisms.
Roosli et al. performed a detailed assessment of cochlear
pathology in patients with VS and also found a lack of
correlation between tumour size and hearing loss. In a
retrospective analysis of temporal bone histopathology they
found that neural mechanisms caused by compression of
the cochlear nerve are not solely responsible for hearing
loss in patients with VS. When compared to the unaffected
ear, VS caused significantly more inner and outer hair cell
loss and cochlear neuronal loss, precipitate in endolymph
and perilymph, and increased pure tone average thresholds.
Moreover, the tumour distance from the cochlea and the
nerve of origin did not correlate with structural changes in
the cochlea or the hearing threshold. Direct invasion of the
modiolus or the cochlea by VS was not observed in any case
[55].
It is nowadays possible to demonstrate endolymphatic
hydrops in vivo through MR imaging [56] and the degree of
endolymphatic hydrops has been shown to correlate with loss
of audiovestibular function in patients withMenière’s disease
[57–59]. MR imaging after local contrast application and
image processing even enables the volumetric quantification
of endolymphatic hydrops [60]. A classical picture of a VS
on T1 weighted MRI after intravenous contrast application is
shown in Figure 1. Figure 2 demonstrates vestibular endolym-
phatic hydrops in a patient with a stable (over 7 years) small





Figure 2: Endolymphatic hydrops and VS seen in a “locally
enhanced inner ear MR imaging” (LEIM), 3D real inversion recov-
ery MRI of the right inner ear after intratympanic Gadolinium con-
trast application. The vestibulum, the horizontal SCC and the basal
turn of the cochlea are visible. Perilymph appears hyperintense,
endolymph appears hypointense (black), and surrounding temporal
bone appears grey. The vestibular endolymphatic space is clearly
enlarged, indicating endolymphatic hydrops.
vestibular schwannoma who developed recurrent vertigo
attacks during follow-up.
Naganawa et al. were able to identify vestibular endolym-
phatic spaces on noncontrast-enhanced 3D FLAIR (fluid
attenuated inversion recovery) MRI. By using intrinsic per-
ilymph signal increase in some patients with VS, endolym-
phatic hydrops was seen in four out of thirteen patients. The
signal increase is attributed to the increased protein concen-
tration [61]. In this small number of patients, there was no
clear-cut correlation between symptoms and endolymphatic
hydrops. However, the results suggest a surprisingly high
prevalence of endolymphatic hydrops inVS patients and raise
the possibility that, in analogy toMenière’s disease, endolym-
phatic hydrops might contribute to audiovestibular function
alterations in VS patients and this also raises the question
whether specific therapeutic interventions directed against
the endolymphatic hydrops might be useful, especially in
patients during observational management of the VS.
It has been suggested thatmetabolic abnormalities caused
by the tumour can have an important impact on the symp-
toms and that in this way abnormalities within the labyrinth
may result in secondary injury to the organ of Corti. Thus,
the progressive hearing loss could be caused by the release
of toxins or potassium ions by the tumour. However, these
metabolites have never been isolated or shown to be causative
[62, 63].
The alteration of inner ear fluid composition in VS
cases seems to play an important role. Different possible
causes for this phenomenon have been described including
impaired labyrinthine blood flow [64, 65], which may be
induced, for example, by intralabyrinthine VS compression
of the labyrinthine artery, cellular immune reactions [66–
68], and/or blockage of neuroaxonal transport mechanisms
[69]. Moreover, acidophilic-staining precipitate in a series of
21 sporadic VS cases has been found [70].
Finally, a small subset of patients may experience a mixed
hearing loss, due to an inner ear conductive loss thought to be
caused by interference with the intracochlear perilymphatic
fluid wave or dampening of stapes movement [71, 72].
The different causes of labyrinthine damage by a VS are
summarized as follows:
Interference of microcirculation by nerve compres-
sion.
Release of toxins or potassium ions by the tumour.
Degeneration of the organ of Corti and the Stria
vascularis.
Changes of inner ear homoeostasis.
Endolymphatic hydrops.
4. Conclusion
In order to preserve the auditory and vestibular function in
VS patients, it is important not only to stop the growth of the
tumour but also to avoid degenerative changes in the inner
ear. A detailed neurotological workup helps in the diagnosis
of VS of all sizes and can also provide useful prognostic
information. In particular, caloric irrigation and unilateral
hearing loss in audiometry have to draw the attention to the
existence of a VS.
As false-negative results remain possible in small
intrameatal tumours (1%) [73] MR imaging is advisable
even if the above tests are negative; in addition, MRI data is
required in patients with positive tests so that an appropriate
treatment plan (surgical intervention or watch and wait
therapy) can be produced. It remains questionable whether
an MRI scan is considered urgent when audiovestibular tests
show no pathologies.
Loss of vestibular function usually occurs slowly and
gradually, allowing an effective central compensation, so
vertigo symptoms are often absent until the loss of function
is severe.
Moreover, extended clinical vestibular function tests
including vHIT and VEMPs can determine the overall extent
of vestibular function loss, especially because the traditional
caloric irrigation can deliver normal results in VS patients.
It has been shown that there is a significant degeneration
of labyrinthine structures in ears with VS. Nevertheless, it is
still unclear whether VS symptoms like hearing loss and ver-
tigo are caused primarily by these labyrinthine mechanisms
or by retrocochlear mechanisms.
Traditionally, VS have often been regarded simply as
retrocochlear lesions. However, otoacoustic emission record-
ings and, in recent years, the endolymphatic hydrops visu-
alization clearly show significant secondary labyrinthine
pathology in patients with VS. Further research, using this
new diagnostic possibility and correlating the morphologic
findings with audiovestibular function test results in patients
with VS will likely provide new insights into the relative con-
tributions of neural versus labyrinthine factors to the patho-
physiology and symptoms of VS. Some symptoms may pos-
sibly arise from labyrinthine factors rather than from neural
factors. Since the inner ear is better accessible to therapeutic
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interventions than the audiovestibular nerve, for example, by
intratympanic application of drugs, new therapeutic possibil-
ities for symptom control in VS patients may possibly arise in
cases where the tumour is stable and does not require invasive
interventions.
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